W. Rathmell
Last active: 4/27/2021

  1. Phase II trial of 5-fluorouracil and leucovorin in combination with interferon-alpha and interleukin-2 for advanced renal cell cancer. Rathmell WK, Malkowicz SB, Holroyde C, Luginbuhl W, Vaughn DJ (2004) Am J Clin Oncol 27(2): 109-12
    › Primary publication · 15057147 (PubMed)
  2. In vitro and in vivo models analyzing von Hippel-Lindau disease-specific mutations. Rathmell WK, Hickey MM, Bezman NA, Chmielecki CA, Carraway NC, Simon MC (2004) Cancer Res 64(23): 8595-603
    › Primary publication · 15574766 (PubMed)
  3. HIF transcription factor expression and induction of hypoxic response genes in a retroperitoneal angiosarcoma. Rathmell WK, Acs G, Simon MC, Vaughn DJ (2004) Anticancer Res 24(1): 167-9
    › Primary publication · 15015593 (PubMed)
  4. Loss of pVHL is sufficient to cause HIF dysregulation in primary cells but does not promote tumor growth. Mack FA, Rathmell WK, Arsham AM, Gnarra J, Keith B, Simon MC (2003) Cancer Cell 3(1): 75-88
    › Primary publication · 12559177 (PubMed) · PMC4120823 (PubMed Central)
  5. The wheat-grain proteome as a basis for more efficient cultivar identification. Skylas DJ, Copeland L, Rathmell WG, Wrigley CW (2001) Proteomics 1(12): 1542-6
    › Primary publication · 11747214 (PubMed)
  6. Yersinia pseudotuberculosis bacteremia and splenic abscess in a patient with non-insulin-dependent diabetes mellitus. Rathmell WK, Arguin P, Chan S, Yu A (1999) West J Med 170(2): 110-2
    › Primary publication · 10063398 (PubMed) · PMC1305451 (PubMed Central)
  7. Failure of hairpin-ended and nicked DNA To activate DNA-dependent protein kinase: implications for V(D)J recombination. Smider V, Rathmell WK, Brown G, Lewis S, Chu G (1998) Mol Cell Biol 18(11): 6853-8
    › Primary publication · 9774698 (PubMed) · PMC109268 (PubMed Central)
  8. DNA-dependent protein kinase is not required for accumulation of p53 or cell cycle arrest after DNA damage. Rathmell WK, Kaufmann WK, Hurt JC, Byrd LL, Chu G (1997) Cancer Res 57(1): 68-74
    › Primary publication · 8988043 (PubMed)
  9. Ku86 defines the genetic defect and restores X-ray resistance and V(D)J recombination to complementation group 5 hamster cell mutants. Errami A, Smider V, Rathmell WK, He DM, Hendrickson EA, Zdzienicka MZ, Chu G (1996) Mol Cell Biol 16(4): 1519-26
    › Primary publication · 8657125 (PubMed) · PMC231136 (PubMed Central)
  10. Restoration of X-ray resistance and V(D)J recombination in mutant cells by Ku cDNA. Smider V, Rathmell WK, Lieber MR, Chu G (1994) Science 266(5183): 288-91
    › Primary publication · 7939667 (PubMed)